Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial

Overview of attention for article published in Respiratory Research, August 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 2 news outlets

twitter: 16 X users

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 30 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

New tests may finally diagnose long COVID

Pediatric News , 30 Nov 2023

One of the biggest challenges facing clinicians who treat long COVID is a lack of consensus when it comes to recognizing and…

New Tests May Finally Diagnose Long COVID

Medscape, 29 Nov 2023

One of the biggest challenges facing clinicians who treat long COVID is a lack of consensus when it comes to recognizing and…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.